Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged between 30 and 70 years old
- People who have been diagnosed with Acute Coronary Syndrome (a serious heart condition where blood flow to the heart is suddenly reduced or blocked)
- People who are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- People who have used certain cholesterol-lowering medications in the three months before signing the consent form, including statins, ezetimibe, or fibrates
- People who have used cholesterol-lowering supplements containing monacolin K in the three months before signing the consent form
- People who have used certain injectable cholesterol-lowering medicines called PCSK9 inhibitors (such as Evolocumab or Alirocumab) in the three months before signing the consent form
- People who have been diagnosed with HIV, cancer, or diabetes (Type 1 or Type 2)
- Female participants who become pregnant during the trial would need to exit the study early
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
characterization of urinary metabolites
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.